Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma.
Combe P, de Guillebon E, Thibault C, Granier C, Tartour E, Oudard S. Combe P, et al. Among authors: tartour e. Oncoimmunology. 2015 Mar 19;4(5):e1001236. doi: 10.1080/2162402X.2014.1001236. eCollection 2015 May. Oncoimmunology. 2015. PMID: 26155388 Free PMC article. Review.
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients.
Adotevi O, Pere H, Ravel P, Haicheur N, Badoual C, Merillon N, Medioni J, Peyrard S, Roncelin S, Verkarre V, Mejean A, Fridman WH, Oudard S, Tartour E. Adotevi O, et al. Among authors: tartour e. J Immunother. 2010 Nov-Dec;33(9):991-8. doi: 10.1097/CJI.0b013e3181f4c208. J Immunother. 2010. PMID: 20948437 Clinical Trial.
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Oudard S, Rixe O, Beuselinck B, Linassier C, Banu E, Machiels JP, Baudard M, Ringeisen F, Velu T, Lefrere-Belda MA, Limacher JM, Fridman WH, Azizi M, Acres B, Tartour E. Oudard S, et al. Among authors: tartour e. Cancer Immunol Immunother. 2011 Feb;60(2):261-71. doi: 10.1007/s00262-010-0935-9. Epub 2010 Nov 11. Cancer Immunol Immunother. 2011. PMID: 21069322 Free PMC article. Clinical Trial.
Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
Tartour E, Pere H, Maillere B, Terme M, Merillon N, Taieb J, Sandoval F, Quintin-Colonna F, Lacerda K, Karadimou A, Badoual C, Tedgui A, Fridman WH, Oudard S. Tartour E, et al. Cancer Metastasis Rev. 2011 Mar;30(1):83-95. doi: 10.1007/s10555-011-9281-4. Cancer Metastasis Rev. 2011. PMID: 21249423 Review.
Trial Watch: Monoclonal antibodies in cancer therapy.
Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: tartour e. Oncoimmunology. 2012 Jan 1;1(1):28-37. doi: 10.4161/onci.1.1.17938. Oncoimmunology. 2012. PMID: 22720209 Free PMC article.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Kroemer G. Vacchelli E, et al. Among authors: tartour e. Oncoimmunology. 2012 Mar 1;1(2):179-188. doi: 10.4161/onci.1.2.19026. Oncoimmunology. 2012. PMID: 22720239 Free PMC article.
Trial Watch: Adoptive cell transfer immunotherapy.
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: tartour e. Oncoimmunology. 2012 May 1;1(3):306-315. doi: 10.4161/onci.19549. Oncoimmunology. 2012. PMID: 22737606 Free PMC article.
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.
Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien VR, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard SP, Tartour E. Pere H, et al. Among authors: tartour e. Oncoimmunology. 2012 May 1;1(3):326-333. doi: 10.4161/onci.18852. Oncoimmunology. 2012. PMID: 22737608 Free PMC article.
314 results